MDxHealth (FRA:O6C1) Cyclically Adjusted Book per Share: €5.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:O6C1 MDxHealth SA FRA:O6C1
32 GF Score
Price €0.33
GF Value €0.95
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is MDxHealth Cyclically Adjusted Book per Share?

MDxHealth FRA:O6C1 -5.11% 32 Cyclically Adjusted Book per Share is €5.11 as of Jun. 2026. GuruFocus rates FRA:O6C1 with a GF Score™ of 32/100 and a GF Value™ of €0.95 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

MDxHealth's adjusted book value per share for the three months ended in Jun. 2026 was €-0.514. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €5.11 for the trailing ten years ended in Jun. 2026.

During the past 12 months, MDxHealth's average Cyclically Adjusted Book Growth Rate was -27.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-23), MDxHealth's current stock price is €0.334. MDxHealth's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €5.11. MDxHealth's Cyclically Adjusted PB Ratio of today is 0.07.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of MDxHealth was 0.77. The lowest was 0.08. And the median was 0.23.


MDxHealth  (FRA:O6C1) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

MDxHealth's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.334/5.11
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of MDxHealth was 0.77. The lowest was 0.08. And the median was 0.23.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


MDxHealth Cyclically Adjusted Book per Share Related Terms


MDxHealth Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for MDxHealth's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MDxHealth Cyclically Adjusted Book per Share Chart

MDxHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 13.20 4.13

MDxHealth Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.05 4.92 4.13 3.89 5.11

FRA:O6C1 vs AWHL, QUCY, BIOQ: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, MDxHealth's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MDxHealth Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MDxHealth's Cyclically Adjusted PB Ratio falls into.


FRA:O6C1
32GF Score
MDxHealth SA FRA:O6C1
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MDxHealth Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MDxHealth's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.514/138.0500*138.0500
=-0.514

Current CPI (Jun. 2026) = 138.0500.

MDxHealth Quarterly Data

Book Value per Share CPI Adj_Book
201112 5.979 96.360 8.566
201206 3.838 97.659 5.425
201212 4.775 98.511 6.692
201306 6.862 99.215 9.548
201312 5.230 99.462 7.259
201406 3.545 99.482 4.919
201412 5.117 99.086 7.129
201506 9.755 100.107 13.452
201512 9.000 100.572 12.354
201606 7.361 102.267 9.937
201612 10.030 102.614 13.494
201706 9.830 103.902 13.061
201712 7.367 104.804 9.704
201806 9.946 106.063 12.946
201812 7.643 107.252 9.838
201906 5.704 107.896 7.298
201912 2.517 108.065 3.215
202006 2.030 108.540 2.582
202012 0.530 108.511 0.674
202106 1.506 110.305 1.885
202109 0.000 111.543 0.000
202112 2.661 114.705 3.203
202203 0.000 118.620 0.000
202206 1.729 120.948 1.973
202209 1.332 124.120 1.481
202212 0.540 126.578 0.589
202303 1.301 126.528 1.419
202306 0.910 125.973 0.997
202309 0.618 127.083 0.671
202312 0.242 128.292 0.260
202403 -0.033 130.552 -0.035
202406 -0.300 130.691 -0.317
202409 0.324 130.968 0.342
202412 0.286 132.346 0.298
202503 0.112 134.348 0.115
202506 -0.015 133.495 -0.016
202509 -0.137 133.740 -0.141
202512 -0.201 135.070 -0.205
202603 -0.341 136.560 -0.345
202606 -0.514 138.050 -0.514

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €5.11 mean?
MDxHealth (FRA:O6C1) has a Cyclically Adjusted Book per Share of €5.11 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on MDxHealth and its competitors.
Is MDxHealth's Cyclically Adjusted Book per Share too high?
MDxHealth's current Cyclically Adjusted Book per Share is €5.11. Overall, MDxHealth has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MDxHealth's Cyclically Adjusted Book per Share compare to AWHL and QUCY?
MDxHealth's Cyclically Adjusted Book per Share of €5.11 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on MDxHealth and its competitors. MDxHealth's current Cyclically Adjusted Book per Share is €5.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MDxHealth stock overvalued right now?
Based on GuruFocus' analysis, MDxHealth (FRA:O6C1) is currently considered Possible Value Trap. The stock's GF Value™ is €0.95, compared to a current price of €0.33 — trading 64.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is €5.11. MDxHealth's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For MDxHealth (FRA:O6C1), the current Cyclically Adjusted Book per Share is €5.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MDxHealth (FRA:O6C1) Overvalued in 2026?

Based on GuruFocus' analysis, MDxHealth stock appears to be undervalued. The current stock price of €0.33 is trading 64.8% below its estimated GF Value™ of €0.95. GuruFocus considers MDxHealth to be Possible Value Trap.

Key valuation signals for FRA:O6C1:

  • Cyclically Adjusted Book per Share: €5.11
  • GF Value™: €0.95 vs. price of €0.33 (64.8% below fair value)
  • GF Score™: 32/100 with 6 warning signs

No single metric tells the full story. See the FRA:O6C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MDxHealth Business Description

Other Exchanges MDXH:USA
Address Zone Industrielle des Hauts-Sarts, Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
32GF Score

Get the complete analysis for FRA:O6C1

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price
€0.95
GF Value